Elanco Animal Health (ELAN) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY25 Guidance

Elanco Animal Health (NYSE: ELAN) reported Q3 EPS of $0.19, $0.06 better than the analyst estimate of $0.13. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.09 billion.

GUIDANCE:

Elanco Animal Health sees FY2025 EPS of $0.91-$0.94, versus the consensus of $0.91. Elanco Animal Health sees FY2025 revenue of $4.65-4.67 billion, versus the consensus of $4.6 billion.

For earnings history and earnings-related data on Elanco Animal Health (ELAN) click here.

You May Also Be Interested In

• KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
• Jefferies Reinstates Talen Energy (TLN) at Hold
• Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming